Gland Pharma fundamental analysis
GLAND
1704.2
49.40 (-2.82%)Last updated on 16 Jan, 2026 | 15:52 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Gland Pharma Fundamentals
P/E Ratio
35.52
P/B Ratio
2.94
Div. Yield
1.06
Sector P/E
69.39
Sector P/B
0.98
Sec. Div. Yield
0.57
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 35.52, compared to the sector average of 69.39. Its P/B Ratio stands at 2.94, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 1.06%, which is than the sector’s 0.57%.
Gland Pharma Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
